$IVZ
Invesco Ltd. Stock $ivz

$ivz Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000091420822000319 Filed on February 18, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$1.763B	$6.895B	$1.630B
YoY Change	8.18%	12.19%	-6.47%
Cost Of Revenue	$540.5M	$2.149B	$507.7M
YoY Change	6.46%	10.36%	-3.86%
Gross Profit	$1.223B	$4.745B	$1.122B
YoY Change	8.95%	13.03%	-7.6%
Gross Profit Margin	69.35%	68.83%	68.85%
Selling, General & Admin	$750.9M	$522.7M	$729.5M
YoY Change	2.93%	-7.34%	-4.47%
% of Gross Profit	61.4%	11.02%	64.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$50.40M	$205.3M	$53.20M
YoY Change	-5.26%	0.88%	1.33%
% of Gross Profit	4.12%	4.33%	4.74%
Operating Expenses	$766.3M	$5.106B	$729.5M
YoY Change	5.04%	-2.28%	-4.47%
Operating Profit	$456.6M	$1.788B	$392.9M
YoY Change	16.21%	94.29%	-12.9%
Interest Expense	$31.40M	$94.70M	$10.70M
YoY Change	193.46%	-26.76%	-173.29%
% of Operating Profit	6.88%	5.3%	2.72%
Other Income/Expense, Net	$147.2M	$120.5M	$171.2M
YoY Change	-14.02%	168.37%	644.35%
Pretax Income	$687.8M	$2.501B	$399.7M
YoY Change	72.08%	133.89%	23.75%
Income Tax	$130.7M	$531.1M	$69.60M
% Of Pretax Income	19.0%	21.24%	17.41%
Net Earnings	$486.0M	$1.393B	$270.3M
YoY Change	79.8%	165.43%	13.1%
Net Earnings / Revenue	27.56%	20.2%	16.58%
Basic Earnings Per Share		$3.01
Diluted Earnings Per Share	$1.046M	$2.99	$582.5K
COMMON SHARES
Basic Shares Outstanding		462.8M shares
Diluted Shares Outstanding		465.4M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.896B	$1.896B	$1.408B
YoY Change	34.69%	34.69%	34.22%
Cash & Equivalents	$1.896B	$1.896B	$1.408B
Short-Term Investments
Other Short-Term Assets	$166.0M	$166.0M	$149.0M
YoY Change	11.41%	11.41%	3.47%
Inventory
Prepaid Expenses
Receivables	$877.8M	$877.8M	$851.0M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.940B	$2.940B	$2.408B
YoY Change	22.1%	22.1%	8.91%
LONG-TERM ASSETS
Property, Plant & Equipment	$518.1M	$774.7M	$563.8M
YoY Change	-8.11%	-7.77%	-3.38%
Goodwill	$8.883B		$8.916B
YoY Change	-0.38%		4.78%
Intangibles	$7.228B		$7.306B
YoY Change	-1.06%		-0.72%
Long-Term Investments	$550.1M	$9.969B	$426.1M
YoY Change	29.1%	14.1%	21.47%
Other Assets
YoY Change
Total Long-Term Assets	$29.75B	$29.75B	$34.10B
YoY Change	-12.76%	-12.76%	-8.37%
TOTAL ASSETS
Total Short-Term Assets	$2.940B	$2.940B	$2.408B
Total Long-Term Assets	$29.75B	$29.75B	$34.10B
Total Assets	$32.69B	$32.69B	$36.50B
YoY Change	-10.46%	-10.46%	-7.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.065B	$775.5M	$1.601B
YoY Change	-33.46%	-51.56%	4.03%
Accrued Expenses	$1.062B	$1.352B	$1.293B
YoY Change	-17.84%	4.57%	-7.38%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.113B	$4.113B	$10.58B
YoY Change	-61.11%	-61.11%	-24.06%
LONG-TERM LIABILITIES
Long-Term Debt	$9.421B	$9.421B	$8.797B
YoY Change	7.1%	7.1%	5.8%
Other Long-Term Liabilities	$846.3M	$846.3M	$589.0M
YoY Change	43.68%	43.68%	-38.0%
Total Long-Term Liabilities	$10.27B	$10.27B	$9.386B
YoY Change	9.39%	9.39%	1.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.113B	$4.113B	$10.58B
Total Long-Term Liabilities	$10.27B	$10.27B	$9.386B
Total Liabilities	$16.01B	$17.19B	$21.48B
YoY Change	-25.49%	-22.37%	-13.09%
SHAREHOLDERS EQUITY
Retained Earnings	$7.169B		$6.085B
YoY Change	17.82%		2.83%
Common Stock	$7.801B		$7.925B
YoY Change	-1.56%		-0.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.044B		$3.254B
YoY Change	-6.46%		-5.76%
Treasury Stock Shares	115.7M shares		121.6M shares
Shareholders Equity	$15.50B	$15.50B	$14.36B
YoY Change
Total Liabilities & Shareholders Equity	$32.69B	$32.69B	$36.50B
YoY Change	-10.46%	-10.46%	-7.4%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$486.0M	$1.393B	$270.3M
YoY Change	79.8%	165.43%	13.1%
Depreciation, Depletion And Amortization	$50.40M	$205.3M	$53.20M
YoY Change	-5.26%	0.88%	1.33%
Cash From Operating Activities	-$16.80M	$1.078B	$564.0M
YoY Change	-102.98%	-12.37%	26.09%
INVESTING ACTIVITIES
Capital Expenditures	-$35.60M	$108.8M	-$41.40M
YoY Change	-14.01%	-5.39%	-14.99%
Acquisitions		$0.00
YoY Change
Other Investing Activities	-$211.1M	-$717.3M	$5.300M
YoY Change	-4083.02%	-4.37%	-100.87%
Cash From Investing Activities	-$246.7M	-$847.9M	-$36.10M
YoY Change	583.38%	-1.36%	-94.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	103.1M	$117.3M	-55.60M
YoY Change	-285.43%	-141.03%	-116.28%
NET CHANGE
Cash From Operating Activities	-16.80M	$1.078B	564.0M
Cash From Investing Activities	-246.7M	-$847.9M	-36.10M
Cash From Financing Activities	103.1M	$117.3M	-55.60M
Net Change In Cash	-160.4M	$347.5M	472.3M
YoY Change	-133.96%	309.79%	255.92%
FREE CASH FLOW
Cash From Operating Activities	-$16.80M	$1.078B	$564.0M
Capital Expenditures	-$35.60M	$108.8M	-$41.40M
Free Cash Flow	$18.80M	$969.3M	$605.4M
YoY Change	-96.89%	-13.09%	22.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0000914208
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2021Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2020Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-13908
CY2021	dei	Entity Registrant Name EntityRegistrantName	Invesco Ltd.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D0
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0557567
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	1555 Peachtree Street, N.E.,
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1800,
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta,
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30309
CY2021	dei	City Area Code CityAreaCode	(404)
CY2021	dei	Local Phone Number LocalPhoneNumber	892-0896
CY2021	dei	Security12b Title Security12bTitle	Common stock, $0.20 par value
CY2021	dei	Trading Symbol TradingSymbol	IVZ
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	9100000000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	460750636	shares
CY2021	dei	Auditor Firm AuditorFirmId	238
CY2021	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2021	dei	Auditor Location AuditorLocation	Atlanta, Georgia
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1896400000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1408400000	USD
CY2021Q4	ivz	Unsettled Fund Receivables UnsettledFundReceivables	92800000	USD
CY2020Q4	ivz	Unsettled Fund Receivables UnsettledFundReceivables	109400000	USD
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	785000000.0	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	741100000	USD
CY2021Q4	us-gaap	Investments Investments	926300000	USD
CY2020Q4	us-gaap	Investments Investments	826800000	USD
CY2021Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	250700000	USD
CY2020Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	301700000	USD
CY2021Q4	ivz	Accountsreceivableandotherassetsofconsolidatedinvestmentproducts Accountsreceivableandotherassetsofconsolidatedinvestmentproducts	532600000	USD
CY2020Q4	ivz	Accountsreceivableandotherassetsofconsolidatedinvestmentproducts Accountsreceivableandotherassetsofconsolidatedinvestmentproducts	175500000	USD
CY2021Q4	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	9042500000	USD
CY2020Q4	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	7910000000	USD
CY2021Q4	us-gaap	Separate Account Assets SeparateAccountAssets	1893600000	USD
CY2020Q4	us-gaap	Separate Account Assets SeparateAccountAssets	7582100000	USD
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	166000000.0	USD
CY2020Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	149200000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	471100000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	514200000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	518100000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	563800000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7228000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7305600000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	8882500000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	8916300000	USD
CY2021Q4	us-gaap	Assets Assets	32685600000	USD
CY2020Q4	us-gaap	Assets Assets	36504100000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	1062300000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	973700000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1065300000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1920400000	USD
CY2021Q4	ivz	Long Term Debt Of Consolidated Investment Products LongTermDebtOfConsolidatedInvestmentProducts	7336100000	USD
CY2020Q4	ivz	Long Term Debt Of Consolidated Investment Products LongTermDebtOfConsolidatedInvestmentProducts	6714100000	USD
CY2021Q4	ivz	Otherliabilitiesofconsolidatedinvestmentproducts Otherliabilitiesofconsolidatedinvestmentproducts	846300000	USD
CY2020Q4	ivz	Otherliabilitiesofconsolidatedinvestmentproducts Otherliabilitiesofconsolidatedinvestmentproducts	588600000	USD
CY2021Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	1893600000	USD
CY2020Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	7582100000	USD
CY2021Q4	ivz	Unsettled Fund Payables UnsettledFundPayables	91800000	USD
CY2020Q4	ivz	Unsettled Fund Payables UnsettledFundPayables	98400000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2085100000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	2082600000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1626300000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1523500000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	16006800000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	21483400000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	510800000	USD
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	211800000	USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.20
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.20
CY2020Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2021Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	4010500000	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	4010500000	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1050000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1050000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	113200000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	113200000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7688000000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7811400000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3043600000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3253800000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7169200000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6085000000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-441500000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-404500000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	15495800000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	14361800000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	672200000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	447100000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16168000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14808900000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32685600000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36504100000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6894500000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6145600000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6117400000	USD
CY2021	ivz	Third Party Distribution Service And Advisory ThirdPartyDistributionServiceAndAdvisory	2149300000	USD
CY2020	ivz	Third Party Distribution Service And Advisory ThirdPartyDistributionServiceAndAdvisory	1947600000	USD
CY2019	ivz	Third Party Distribution Service And Advisory ThirdPartyDistributionServiceAndAdvisory	1893000000	USD
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1911300000	USD
CY2020	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1807900000	USD
CY2019	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1709300000	USD
CY2021	us-gaap	Marketing Expense MarketingExpense	98600000	USD
CY2020	us-gaap	Marketing Expense MarketingExpense	83300000	USD
CY2019	us-gaap	Marketing Expense MarketingExpense	135600000	USD
CY2021	us-gaap	Communications Information Technology And Occupancy CommunicationsInformationTechnologyAndOccupancy	526000000.0	USD
CY2020	us-gaap	Communications Information Technology And Occupancy CommunicationsInformationTechnologyAndOccupancy	512300000	USD
CY2019	us-gaap	Communications Information Technology And Occupancy CommunicationsInformationTechnologyAndOccupancy	494100000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	424100000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	5309200000	USD
CY2019	ivz	Total Transaction And Integration Charges TotalTransactionAndIntegrationCharges	620300000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62900000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	480800000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	404200000	USD
CY2021	ivz	Total Transaction And Integration Charges TotalTransactionAndIntegrationCharges	-65900000	USD
CY2020	ivz	Total Transaction And Integration Charges TotalTransactionAndIntegrationCharges	330800000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62500000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	52700000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	5106300000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	5225200000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	1788200000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	920400000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	808200000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	152300000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	72700000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	56400000	USD
CY2021	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	25200000	USD
CY2020	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	20500000	USD
CY2019	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	28500000	USD
CY2021	us-gaap	Interest Expense InterestExpense	94700000	USD
CY2020	us-gaap	Interest Expense InterestExpense	129300000	USD
CY2019	us-gaap	Interest Expense InterestExpense	135700000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	120500000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	44900000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	65700000	USD
CY2021	ivz	Other Non Operating Income Expense Consolidated Investment Products OtherNonOperatingIncomeExpenseConsolidatedInvestmentProducts	509000000.0	USD
CY2020	ivz	Other Non Operating Income Expense Consolidated Investment Products OtherNonOperatingIncomeExpenseConsolidatedInvestmentProducts	139900000	USD
CY2019	ivz	Other Non Operating Income Expense Consolidated Investment Products OtherNonOperatingIncomeExpenseConsolidatedInvestmentProducts	149800000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2500500000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1069100000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	972900000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	531100000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	261600000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	235100000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	1969400000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	807500000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	737800000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	339600000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	45900000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	49500000	USD
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	236800000	USD
CY2020	us-gaap	Dividends Preferred Stock DividendsPreferredStock	236800000	USD
CY2019	us-gaap	Dividends Preferred Stock DividendsPreferredStock	123600000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	1393000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	524800000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	564700000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.01
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.14
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.29
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.99
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.13
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.28
CY2021	us-gaap	Profit Loss ProfitLoss	1969400000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	807500000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	737800000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-73300000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	182700000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	155600000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-28300000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	6300000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	10800000	USD
CY2021	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	8000000.0	USD
CY2020	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	6400000	USD
CY2019	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	2900000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-37000000.0	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	182800000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	147700000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1932400000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	990300000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	885500000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	339600000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	45900000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	49500000	USD
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	236800000	USD
CY2020	us-gaap	Dividends Preferred Stock DividendsPreferredStock	236800000	USD
CY2019	us-gaap	Dividends Preferred Stock DividendsPreferredStock	123600000	USD
CY2021	ivz	Comprehensive Income Net Of Tax Basic ComprehensiveIncomeNetOfTaxBasic	1356000000	USD
CY2020	ivz	Comprehensive Income Net Of Tax Basic ComprehensiveIncomeNetOfTaxBasic	707600000	USD
CY2019	ivz	Comprehensive Income Net Of Tax Basic ComprehensiveIncomeNetOfTaxBasic	712400000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-748900000	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	120500000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	44900000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	1969400000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	807500000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	737800000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	205300000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	203500000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	177600000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	140100000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	188500000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	207500000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	65700000	USD
CY2021	ivz	Gains And Losses Of Consolidated Investment Products Net GainsAndLossesOfConsolidatedInvestmentProductsNet	390000000.0	USD
CY2020	ivz	Gains And Losses Of Consolidated Investment Products Net GainsAndLossesOfConsolidatedInvestmentProductsNet	32100000	USD
CY2019	ivz	Gains And Losses Of Consolidated Investment Products Net GainsAndLossesOfConsolidatedInvestmentProductsNet	32900000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	152300000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	72700000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	56400000	USD
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	48200000	USD
CY2020	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	33900000	USD
CY2019	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	9700000	USD
CY2021	ivz	Purchasesaleofinvestmentsby Ci Pnet PurchasesaleofinvestmentsbyCIPnet	421600000	USD
CY2020	ivz	Purchasesaleofinvestmentsby Ci Pnet PurchasesaleofinvestmentsbyCIPnet	48200000	USD
CY2019	ivz	Purchasesaleofinvestmentsby Ci Pnet PurchasesaleofinvestmentsbyCIPnet	213400000	USD
CY2021	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-93800000	USD
CY2020	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-263100000	USD
CY2019	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-167000000.0	USD
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-5581200000	USD
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-3744400000	USD
CY2019	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-934300000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5875500000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3812700000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1078100000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1230300000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1116600000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	108800000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	115000000.0	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	124300000	USD
CY2021	ivz	Purchase Of Investments By Consolidated Investment Products PurchaseOfInvestmentsByConsolidatedInvestmentProducts	5981800000	USD
CY2020	ivz	Purchase Of Investments By Consolidated Investment Products PurchaseOfInvestmentsByConsolidatedInvestmentProducts	4548600000	USD
CY2019	ivz	Purchase Of Investments By Consolidated Investment Products PurchaseOfInvestmentsByConsolidatedInvestmentProducts	5244800000	USD
CY2021	ivz	Proceeds From Sale Of Investments By Consolidated Investment Products ProceedsFromSaleOfInvestmentsByConsolidatedInvestmentProducts	5281500000	USD
CY2020	ivz	Proceeds From Sale Of Investments By Consolidated Investment Products ProceedsFromSaleOfInvestmentsByConsolidatedInvestmentProducts	3782300000	USD
CY2019	ivz	Proceeds From Sale Of Investments By Consolidated Investment Products ProceedsFromSaleOfInvestmentsByConsolidatedInvestmentProducts	3654900000	USD
CY2021	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	191100000	USD
CY2020	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	153600000	USD
CY2019	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	229100000	USD
CY2021	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	129200000	USD
CY2020	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	143200000	USD
CY2019	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	123300000	USD
CY2021	ivz	Proceeds From Returns Of Capital And Distributions From Equity Method Investments ProceedsFromReturnsOfCapitalAndDistributionsFromEquityMethodInvestments	44900000	USD
CY2020	ivz	Proceeds From Returns Of Capital And Distributions From Equity Method Investments ProceedsFromReturnsOfCapitalAndDistributionsFromEquityMethodInvestments	26600000	USD
CY2019	ivz	Proceeds From Returns Of Capital And Distributions From Equity Method Investments ProceedsFromReturnsOfCapitalAndDistributionsFromEquityMethodInvestments	78100000	USD
CY2021	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	0	USD
CY2020	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	0	USD
CY2019	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	-26000000.0	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-290500000	USD
CY2021	ivz	Proceeds From Payments To Consolidation And Deconsolidation Of Subsidiaries ProceedsFromPaymentsToConsolidationAndDeconsolidationOfSubsidiaries	-21800000	USD
CY2020	ivz	Proceeds From Payments To Consolidation And Deconsolidation Of Subsidiaries ProceedsFromPaymentsToConsolidationAndDeconsolidationOfSubsidiaries	5500000	USD
CY2019	ivz	Proceeds From Payments To Consolidation And Deconsolidation Of Subsidiaries ProceedsFromPaymentsToConsolidationAndDeconsolidationOfSubsidiaries	-7400000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-847900000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-859600000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1432800000	USD
CY2021	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	60900000	USD
CY2020	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	47100000	USD
CY2019	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	469800000	USD
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	236800000	USD
CY2020	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	236800000	USD
CY2019	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	123600000	USD
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	307700000	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	357400000	USD
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	529100000	USD
CY2021	ivz	Capital Invested Into Consolidated Investment Products CapitalInvestedIntoConsolidatedInvestmentProducts	628900000	USD
CY2020	ivz	Capital Invested Into Consolidated Investment Products CapitalInvestedIntoConsolidatedInvestmentProducts	185800000	USD
CY2019	ivz	Capital Invested Into Consolidated Investment Products CapitalInvestedIntoConsolidatedInvestmentProducts	289500000	USD
CY2021	ivz	Capital Distributed By Consolidated Investment Products CapitalDistributedByConsolidatedInvestmentProducts	395500000	USD
CY2020	ivz	Capital Distributed By Consolidated Investment Products CapitalDistributedByConsolidatedInvestmentProducts	236400000	USD
CY2019	ivz	Capital Distributed By Consolidated Investment Products CapitalDistributedByConsolidatedInvestmentProducts	144100000	USD
CY2021	ivz	Proceedsfrom Debt Consolidated Investment Products ProceedsfromDebtConsolidatedInvestmentProducts	3411900000	USD
CY2020	ivz	Proceedsfrom Debt Consolidated Investment Products ProceedsfromDebtConsolidatedInvestmentProducts	1268000000	USD
CY2019	ivz	Proceedsfrom Debt Consolidated Investment Products ProceedsfromDebtConsolidatedInvestmentProducts	3348800000	USD
CY2021	ivz	Repayments Of Consolidated Investment Products RepaymentsOfConsolidatedInvestmentProducts	2497300000	USD
CY2020	ivz	Repayments Of Consolidated Investment Products RepaymentsOfConsolidatedInvestmentProducts	791100000	USD
CY2019	ivz	Repayments Of Consolidated Investment Products RepaymentsOfConsolidatedInvestmentProducts	1819600000	USD
CY2021	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	309400000	USD
CY2020	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	190600000	USD
CY2019	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
CY2021	ivz	Proceeds From Payments For Collateral Financing Activities ProceedsFromPaymentsForCollateralFinancingActivities	-104100000	USD
CY2020	ivz	Proceeds From Payments For Collateral Financing Activities ProceedsFromPaymentsForCollateralFinancingActivities	142000000.0	USD
CY2019	ivz	Proceeds From Payments For Collateral Financing Activities ProceedsFromPaymentsForCollateralFinancingActivities	0	USD
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	USD
CY2020	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	USD
CY2019	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-330800000	USD
CY2021	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	11800000	USD
CY2020	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	22300000	USD
CY2019	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	20000000.0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	117300000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-285900000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	201300000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	347500000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	84800000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-114900000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-32200000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	27500000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	17700000	USD
CY2021	ivz	Effectof Exchange Rateon Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Cip EffectofExchangeRateonCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsCIP	-7500000	USD
CY2020	ivz	Effectof Exchange Rateon Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Cip EffectofExchangeRateonCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsCIP	25800000	USD
CY2019	ivz	Effectof Exchange Rateon Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Cip EffectofExchangeRateonCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsCIP	-7000000.0	USD
CY2020Q4	ivz	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Including Cip CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsIncludingCIP	1839300000	USD
CY2019Q4	ivz	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Including Cip CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsIncludingCIP	1701200000	USD
CY2018Q4	ivz	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Including Cip CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsIncludingCIP	1805400000	USD
CY2021Q4	ivz	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Including Cip CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsIncludingCIP	2147100000	USD
CY2020Q4	ivz	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Including Cip CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsIncludingCIP	1839300000	USD
CY2019Q4	ivz	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Including Cip CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsIncludingCIP	1701200000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1896400000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1408400000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1049000000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	129200000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2021Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	250700000	USD
CY2020Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	301700000	USD
CY2019Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	652200000	USD
CY2021Q4	ivz	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Including Cip CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsIncludingCIP	2147100000	USD
CY2020Q4	ivz	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Including Cip CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsIncludingCIP	1839300000	USD
CY2019Q4	ivz	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Including Cip CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsIncludingCIP	1701200000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	85700000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	93100000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	99400000	USD
CY2021	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	700000	USD
CY2020	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	2700000	USD
CY2019	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	9200000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	431700000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	223800000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	193700000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	129200000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14808900000	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	211800000	USD
CY2021	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	1931400000	USD
CY2021	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	38000000.0	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-37000000.0	USD
CY2021	ivz	Change In Noncontrolling Interests In Consolidated Entities Net ChangeInNoncontrollingInterestsInConsolidatedEntitiesNet	76500000	USD
CY2021	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	261000000.0	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2021	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	59.00
CY2021	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	236800000	USD
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.67
CY2021	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	308800000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	140100000	USD
CY2021	ivz	Othershareawards Othershareawards	7600000	USD
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	60900000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16168000000	USD
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	510800000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14318300000	USD
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	383500000	USD
CY2020	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	796300000	USD
CY2020	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	11200000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	182800000	USD
CY2020	ivz	Money Market Fee Waiver MoneyMarketFeeWaiver	40700000	USD
CY2020	ivz	Change In Noncontrolling Interests In Consolidated Entities Net ChangeInNoncontrollingInterestsInConsolidatedEntitiesNet	43400000	USD
CY2020	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-182900000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2020	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	59.00
CY2020	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	236800000	USD
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.78
CY2020	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	357600000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	188500000	USD
CY2020	ivz	Othershareawards Othershareawards	7900000	USD
CY2020	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	47100000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14808900000	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	211800000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8936200000	USD
CY2018Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	396200000	USD
CY2019	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	697800000	USD
CY2019	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	40000000.0	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	147700000	USD
CY2019	ivz	Change In Noncontrolling Interests In Consolidated Entities Net ChangeInNoncontrollingInterestsInConsolidatedEntitiesNet	-88900000	USD
CY2019	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-52700000	USD
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5463800000	USD
CY2019	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	30.81
CY2019	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	123600000	USD
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.23
CY2019	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	531400000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	207500000	USD
CY2019	ivz	Vested Shares VestedShares	-88700000	USD
CY2019	ivz	Othershareawards Othershareawards	7500000	USD
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	664800000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14318300000	USD
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	383500000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="padding-left:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing the Consolidated Financial Statements, management is required to make estimates and assumptions that affect reported revenues, expenses, assets, liabilities and disclosure of contingent liabilities. The primary estimates and assumptions made relate to goodwill and intangible impairment, certain investments which are carried at fair value, post-employment benefit plan obligations, income taxes and contingent losses. Additionally, estimation is involved when determining investment and debt valuation for certain CIP; however, changes in the fair values of these amounts are largely offset by noncontrolling interests. Use of available information and application of judgment are inherent in the formation of estimates. Actual results in the future could differ from such estimates, and the differences may be material to the Consolidated Financial Statements.</span></div>
CY2021	ivz	Non Controlling Interest In Acquisitions NonControllingInterestInAcquisitions	1
CY2021	ivz	Recognized Liabilities Acquired RecognizedLiabilitiesAcquired	1
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reporting_unit
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reporting_unit
CY2021	ivz	Money Market Fee Waiver MoneyMarketFeeWaiver	153700000	USD
CY2021	ivz	Share Based Payment Estimated Forfeitures Percentage ShareBasedPaymentEstimatedForfeituresPercentage	0.03
CY2021	ivz	Percentage Of Excess In Projected Benefit Obligation And Fair Value Assets To Be Amortized PercentageOfExcessInProjectedBenefitObligationAndFairValueAssetsToBeAmortized	0.100
CY2021	ivz	Percentage Of Excess In Projected Benefit Obligation And Fair Value Assets To Be Amortized PercentageOfExcessInProjectedBenefitObligationAndFairValueAssetsToBeAmortized	0.100
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7228000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7512600000	USD
CY2021Q4	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	1893600000	USD
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	1600000	USD
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	3503100000	USD
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1300000	USD
CY2020Q4	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	7582100000	USD
CY2020Q4	us-gaap	Derivative Assets DerivativeAssets	5100000	USD
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	8894800000	USD
CY2020Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	18600000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	550100000	USD
CY2021Q4	us-gaap	Other Investments OtherInvestments	7900000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	426100000	USD
CY2020Q4	us-gaap	Other Investments OtherInvestments	10500000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	550100000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	426100000	USD
CY2021Q4	ivz	Foreign Time Deposits ForeignTimeDeposits	30400000	USD
CY2020Q4	ivz	Foreign Time Deposits ForeignTimeDeposits	29900000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	207000000.0	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7305600000	USD
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2021Q4	us-gaap	Other Investments OtherInvestments	7900000	USD
CY2020Q4	us-gaap	Other Investments OtherInvestments	10500000	USD
CY2021Q4	us-gaap	Investments Investments	926300000	USD
CY2020Q4	us-gaap	Investments Investments	826800000	USD
CY2021	ivz	Net Realizedand Unrealized Gainon Trading Securities NetRealizedandUnrealizedGainonTradingSecurities	58100000	USD
CY2020	ivz	Net Realizedand Unrealized Gainon Trading Securities NetRealizedandUnrealizedGainonTradingSecurities	41700000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1597000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1569900000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1078900000	USD
CY2020	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2020	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62900000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62500000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	52700000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	60100000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	8916300000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1006100000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	518100000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	563800000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	17800000	USD
CY2020	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	4400000	USD
CY2020	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	13400000	USD
CY2021	us-gaap	Depreciation Nonproduction DepreciationNonproduction	142400000	USD
CY2020	us-gaap	Depreciation Nonproduction DepreciationNonproduction	141000000	USD
CY2019	us-gaap	Depreciation Nonproduction DepreciationNonproduction	124900000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7495300000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	267300000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	52000000.0	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	46300000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	39200000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	37300000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	58000000	USD
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1600000	USD
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-35400000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	8882500000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	8509400000	USD
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	285800000	USD
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	121100000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	8916300000	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	121200000	USD
CY2020Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	148200000	USD
CY2021Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	941100000	USD
CY2020Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	825500000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	1062300000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	973700000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5500000	USD
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	382400000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	384200000	USD
CY2021Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	USD
CY2020Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	387800000	USD
CY2021Q4	us-gaap	Derivative Asset Fair Value Of Collateral DerivativeAssetFairValueOfCollateral	0	USD
CY2020Q4	us-gaap	Derivative Asset Fair Value Of Collateral DerivativeAssetFairValueOfCollateral	104100000	USD
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	309000000.0	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	289800000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	319200000	USD
CY2021Q4	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	312500000	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	348900000	USD
CY2021Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	80600000	USD
CY2020Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	67200000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1065300000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1920400000	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	900000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000.0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000.0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000.0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000.0	shares
CY2019Q2	ivz	Preferred Stock Lockup Period PreferredStockLockupPeriod	P5Y
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2021Q4	ivz	Treasury Stock Shares For Which Dividendand Voting Rights Do Not Apply TreasuryStockSharesForWhichDividendandVotingRightsDoNotApply	104900000	shares
CY2020Q4	ivz	Treasury Stock Shares For Which Dividendand Voting Rights Do Not Apply TreasuryStockSharesForWhichDividendandVotingRightsDoNotApply	107000000.0	shares
CY2019Q4	ivz	Treasury Stock Shares For Which Dividendand Voting Rights Do Not Apply TreasuryStockSharesForWhichDividendandVotingRightsDoNotApply	112800000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	461200000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	459100000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	453300000	shares
CY2020	us-gaap	Forward Contract Indexed To Issuers Equity Shares ForwardContractIndexedToIssuersEquityShares	0	shares
CY2020	us-gaap	Forward Contract Indexed To Issuers Equity Shares ForwardContractIndexedToIssuersEquityShares	0	shares
CY2021	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	2700000	shares
CY2020	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	3400000	shares
CY2021	ivz	Fair Value Of Shares Withheld FairValueOfSharesWithheld	60900000	USD
CY2020	ivz	Fair Value Of Shares Withheld FairValueOfSharesWithheld	47100000	USD
CY2021Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	732200000	USD
CY2020Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	732200000	USD
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	115700000	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	121600000	shares
CY2021Q4	ivz	Treasury Shares Held As Unvested Restricted Stock Awards TreasurySharesHeldAsUnvestedRestrictedStockAwards	10800000	shares
CY2020Q4	ivz	Treasury Shares Held As Unvested Restricted Stock Awards TreasurySharesHeldAsUnvestedRestrictedStockAwards	14600000	shares
CY2021	ivz	Common Shares Market Price Per Share CommonSharesMarketPricePerShare	23.02
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	115700000	shares
CY2021	ivz	Treasury Stock Common Shares Aggregate Market Value TreasuryStockCommonSharesAggregateMarketValue	2700000000	USD
CY2020Q4	ivz	Treasury Stock Held Including Shares For Unvested Restricted Stock Awards TreasuryStockHeldIncludingSharesForUnvestedRestrictedStockAwards	121600000	shares
CY2019Q4	ivz	Treasury Stock Held Including Shares For Unvested Restricted Stock Awards TreasuryStockHeldIncludingSharesForUnvestedRestrictedStockAwards	128200000	shares
CY2018Q4	ivz	Treasury Stock Held Including Shares For Unvested Restricted Stock Awards TreasuryStockHeldIncludingSharesForUnvestedRestrictedStockAwards	103000000.0	shares
CY2021	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2700000	shares
CY2020	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	3400000	shares
CY2019	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	34700000	shares
CY2021	ivz	Treasury Stock Common Shares Distributed TreasuryStockCommonSharesDistributed	8400000	shares
CY2020	ivz	Treasury Stock Common Shares Distributed TreasuryStockCommonSharesDistributed	9300000	shares
CY2019	ivz	Treasury Stock Common Shares Distributed TreasuryStockCommonSharesDistributed	9200000	shares
CY2021	ivz	Commonsharesdistributedtomeet Esp Pobligation CommonsharesdistributedtomeetESPPobligation	200000	shares
CY2020	ivz	Commonsharesdistributedtomeet Esp Pobligation CommonsharesdistributedtomeetESPPobligation	700000	shares
CY2019	ivz	Commonsharesdistributedtomeet Esp Pobligation CommonsharesdistributedtomeetESPPobligation	300000	shares
CY2021Q4	ivz	Treasury Stock Held Including Shares For Unvested Restricted Stock Awards TreasuryStockHeldIncludingSharesForUnvestedRestrictedStockAwards	115700000	shares
CY2020Q4	ivz	Treasury Stock Held Including Shares For Unvested Restricted Stock Awards TreasuryStockHeldIncludingSharesForUnvestedRestrictedStockAwards	121600000	shares
CY2019Q4	ivz	Treasury Stock Held Including Shares For Unvested Restricted Stock Awards TreasuryStockHeldIncludingSharesForUnvestedRestrictedStockAwards	128200000	shares
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-73300000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-28300000	USD
CY2021	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	8000000.0	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-37000000.0	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-37000000.0	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	182700000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	6300000	USD
CY2020	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	6400000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	182800000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	182800000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	155600000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	10800000	USD
CY2019	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	2900000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	147700000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	147700000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1600000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-2400000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-6500000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	140100000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	188500000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	207500000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	30000000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	27800000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	38100000	USD
CY2021	ivz	Number Of Share Awards By Type NumberOfShareAwardsByType	2	award
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	19.11
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	22.61
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	18.90
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	21.40
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	18.88
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	187900000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	124600000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	177100000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	22.61
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	14.09
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	19.66
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	164700000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M13D
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	39300000	USD
CY2020	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	119000000	USD
CY2020Q2	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
CY2021	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	100500000	USD
	us-gaap	Restructuring Charges RestructuringCharges	94100000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	49600000	USD
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	44500000	USD
CY2021	us-gaap	Restructuring Charges RestructuringCharges	78000000.0	USD
CY2021	us-gaap	Payments For Restructuring PaymentsForRestructuring	87700000	USD
CY2021Q4	us-gaap	Restructuring Reserve RestructuringReserve	34800000	USD
	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	24900000	USD
CY2021	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	22500000	USD
	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	47400000	USD
CY2021Q4	us-gaap	Restructuring And Related Cost Cost Incurred To Date1 RestructuringAndRelatedCostCostIncurredToDate1	219500000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y4M28D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y8M26D
CY2021Q4	ivz	Lessee Operating Lease Number Of Renewal Options LesseeOperatingLeaseNumberOfRenewalOptions	1	lease_renewal_option
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	256600000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	289800000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	81400000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	91600000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	70000000.0	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	25500000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	23400000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	26800000	USD
CY2021	us-gaap	Sublease Income SubleaseIncome	1900000	USD
CY2020	us-gaap	Sublease Income SubleaseIncome	2100000	USD
CY2019	us-gaap	Sublease Income SubleaseIncome	600000	USD
CY2021	us-gaap	Lease Cost LeaseCost	105000000.0	USD
CY2020	us-gaap	Lease Cost LeaseCost	112900000	USD
CY2019	us-gaap	Lease Cost LeaseCost	96200000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	17800000	USD
CY2020	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	13400000	USD
CY2020	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	4400000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	86000000.0	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	98300000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7700000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	36700000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0335
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0339
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	77500000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	64900000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	47800000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	34700000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	51300000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	315500000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	25700000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	289800000	USD
CY2021Q4	ivz	Lessee Operating Lease Lease Not Yet Commenced Liability LesseeOperatingLeaseLeaseNotYetCommencedLiability	232500000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1 LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1	P15Y
CY2021	ivz	Net Realizedand Unrealized Gainon Trading Securities NetRealizedandUnrealizedGainonTradingSecurities	58100000	USD
CY2020	ivz	Net Realizedand Unrealized Gainon Trading Securities NetRealizedandUnrealizedGainonTradingSecurities	41700000	USD
CY2019	ivz	Net Realizedand Unrealized Gainon Trading Securities NetRealizedandUnrealizedGainonTradingSecurities	82500000	USD
CY2021	ivz	Gainoncontingentconsiderationliability Gainoncontingentconsiderationliability	10100000	USD
CY2020	ivz	Gainoncontingentconsiderationliability Gainoncontingentconsiderationliability	15300000	USD
CY2019	ivz	Gainoncontingentconsiderationliability Gainoncontingentconsiderationliability	0	USD
CY2021	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax	3300000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax	100000	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax	0	USD
CY2021	ivz	Other Realized Gains OtherRealizedGains	56800000	USD
CY2020	ivz	Other Realized Gains OtherRealizedGains	1000000.0	USD
CY2019	ivz	Other Realized Gains OtherRealizedGains	0	USD
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2020	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2019	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	1500000	USD
CY2021	ivz	Net Gain Generated Upon Debt Tender Offer NetGainGeneratedUponDebtTenderOffer	0	USD
CY2020	ivz	Net Gain Generated Upon Debt Tender Offer NetGainGeneratedUponDebtTenderOffer	2500000	USD
CY2019	ivz	Net Gain Generated Upon Debt Tender Offer NetGainGeneratedUponDebtTenderOffer	5200000	USD
CY2021	ivz	Other Non Operating Gains OtherNonOperatingGains	128300000	USD
CY2020	ivz	Other Non Operating Gains OtherNonOperatingGains	60600000	USD
CY2019	ivz	Other Non Operating Gains OtherNonOperatingGains	89200000	USD
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	7100000	USD
CY2020	us-gaap	Impairment Of Investments ImpairmentOfInvestments	3600000	USD
CY2019	us-gaap	Impairment Of Investments ImpairmentOfInvestments	2000000.0	USD
CY2021	us-gaap	Pension Expense PensionExpense	700000	USD
CY2020	us-gaap	Pension Expense PensionExpense	0	USD
CY2019	us-gaap	Pension Expense PensionExpense	0	USD
CY2021	us-gaap	Loss Contingency Accrual Carrying Value Period Increase Decrease LossContingencyAccrualCarryingValuePeriodIncreaseDecrease	0	USD
CY2020	us-gaap	Loss Contingency Accrual Carrying Value Period Increase Decrease LossContingencyAccrualCarryingValuePeriodIncreaseDecrease	0	USD
CY2019	us-gaap	Loss Contingency Accrual Carrying Value Period Increase Decrease LossContingencyAccrualCarryingValuePeriodIncreaseDecrease	7800000	USD
CY2021	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	0	USD
CY2020	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	2400000	USD
CY2019	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	8900000	USD
CY2021	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	0	USD
CY2020	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	0	USD
CY2019	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	4800000	USD
CY2021	ivz	Other Non Operating Realized Losses OtherNonOperatingRealizedLosses	0	USD
CY2020	ivz	Other Non Operating Realized Losses OtherNonOperatingRealizedLosses	9700000	USD
CY2019	ivz	Other Non Operating Realized Losses OtherNonOperatingRealizedLosses	0	USD
CY2021	ivz	Other Non Operating Losses OtherNonOperatingLosses	7800000	USD
CY2020	ivz	Other Non Operating Losses OtherNonOperatingLosses	15700000	USD
CY2019	ivz	Other Non Operating Losses OtherNonOperatingLosses	23500000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	120500000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	44900000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	65700000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	287500000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	125100000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	102000000.0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	68700000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	19700000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	17000000.0	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	95200000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	35500000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	94000000.0	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	451400000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	180300000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	213000000.0	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	72700000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	57600000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	16600000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	22200000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	5200000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	4300000	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-15200000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	18500000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	1200000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	79700000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	81300000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	175100000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	22100000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	531100000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	261600000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	235100000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.004
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.005
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.003
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.029
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.019
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.018
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.001
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.013
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.009
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.029
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.009
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.011
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	-0.009
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	-0.010
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	-0.005
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.016
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.017
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.024
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.212
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.245
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.242
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	2089500000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	845800000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	511100000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	411000000.0	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	223300000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	461800000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2500500000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1069100000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	972900000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	125900000	USD
CY2021Q4	ivz	Deferred Tax Assets Lease Obligation DeferredTaxAssetsLeaseObligation	36400000	USD
CY2020Q4	ivz	Deferred Tax Assets Lease Obligation DeferredTaxAssetsLeaseObligation	44500000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	119000000.0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	99800000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	29700000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	97700000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1400000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	55400000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	361600000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	423300000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	86700000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	104500000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	274900000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	318800000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	1787100000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	1745400000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	33300000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	40300000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	18200000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	27800000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	42700000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	22900000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1881300000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1836400000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1606400000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1517600000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1626300000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1523500000	USD
CY2021Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	1090000000	USD
CY2020Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	1060000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	61900000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	69900000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	20000000.0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	15900000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	6600000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1400000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	14200000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	2200000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1200000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	54100000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	3500000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	9900000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	4000000.0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1900000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	6900000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2800000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	86600000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	61900000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	69900000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	71900000	USD
CY2021Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	14800000	USD
CY2020Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	13200000	USD
CY2019Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	11700000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	1393000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	524800000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	564700000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	462800000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	459500000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	437800000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2600000	shares
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3000000.0	shares
CY2019	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2700000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	465400000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	462500000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	440500000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.01
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.14
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.29
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.99
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.13
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.28
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	700000	shares
CY2021	ivz	Contingently Issuable Share Excluded ContingentlyIssuableShareExcluded	0	shares
CY2020	ivz	Contingently Issuable Share Excluded ContingentlyIssuableShareExcluded	0	shares
CY2019	ivz	Contingently Issuable Share Excluded ContingentlyIssuableShareExcluded	0	shares
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6894500000	USD
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	518100000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6145600000	USD
CY2020Q4	us-gaap	Noncurrent Assets NoncurrentAssets	563800000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6117400000	USD
CY2019Q4	us-gaap	Noncurrent Assets NoncurrentAssets	583500000	USD
CY2021	ivz	Undrawn Capital Commitments UndrawnCapitalCommitments	488800000	USD
CY2020	ivz	Undrawn Capital Commitments UndrawnCapitalCommitments	453500000	USD
CY2021Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	250700000	USD
CY2020Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	301700000	USD
CY2021Q4	ivz	Accountsreceivableandotherassetsofconsolidatedinvestmentproducts Accountsreceivableandotherassetsofconsolidatedinvestmentproducts	532600000	USD
CY2020Q4	ivz	Accountsreceivableandotherassetsofconsolidatedinvestmentproducts Accountsreceivableandotherassetsofconsolidatedinvestmentproducts	175500000	USD
CY2021Q4	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	9042500000	USD
CY2020Q4	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	7910000000	USD
CY2021Q4	ivz	Long Term Debt Of Consolidated Investment Products LongTermDebtOfConsolidatedInvestmentProducts	7336100000	USD
CY2020Q4	ivz	Long Term Debt Of Consolidated Investment Products LongTermDebtOfConsolidatedInvestmentProducts	6714100000	USD
CY2021Q4	ivz	Otherliabilitiesofconsolidatedinvestmentproducts Otherliabilitiesofconsolidatedinvestmentproducts	846300000	USD
CY2020Q4	ivz	Otherliabilitiesofconsolidatedinvestmentproducts Otherliabilitiesofconsolidatedinvestmentproducts	588600000	USD
CY2021Q4	ivz	Retainedearningsadjustmentfor Cip RetainedearningsadjustmentforCIP	100000	USD
CY2020Q4	ivz	Retainedearningsadjustmentfor Cip RetainedearningsadjustmentforCIP	100000	USD
CY2021Q4	ivz	Redeemable Noncontrolling Interest Consolidated Investment Products RedeemableNoncontrollingInterestConsolidatedInvestmentProducts	510800000	USD
CY2020Q4	ivz	Redeemable Noncontrolling Interest Consolidated Investment Products RedeemableNoncontrollingInterestConsolidatedInvestmentProducts	211800000	USD
CY2021Q4	ivz	Nonredeemable Noncontrolling Interest Consolidated Investment Products NonredeemableNoncontrollingInterestConsolidatedInvestmentProducts	671500000	USD
CY2020Q4	ivz	Nonredeemable Noncontrolling Interest Consolidated Investment Products NonredeemableNoncontrollingInterestConsolidatedInvestmentProducts	446300000	USD
CY2020Q4	ivz	Collateral Assets Default Percentage CollateralAssetsDefaultPercentage	0.0117
CY2021Q4	ivz	Net Interests In Consolidated Investment Products NetInterestsInConsolidatedInvestmentProducts	461200000	USD
CY2020Q4	ivz	Net Interests In Consolidated Investment Products NetInterestsInConsolidatedInvestmentProducts	426500000	USD
CY2021	ivz	Variable Interest Entity Nonconsolidated Numberof Entities VariableInterestEntityNonconsolidatedNumberofEntities	7	entity
CY2021	ivz	Voting Rights Entity Nonconsolidated Numberof Entities VotingRightsEntityNonconsolidatedNumberofEntities	6	entity
CY2020	ivz	Variable Interest Entity Nonconsolidated Numberof Entities VariableInterestEntityNonconsolidatedNumberofEntities	15	entity
CY2020	ivz	Voting Rights Entity Nonconsolidated Numberof Entities VotingRightsEntityNonconsolidatedNumberofEntities	11	entity
CY2021	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
CY2020	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
CY2021Q4	us-gaap	Real Estate Investments RealEstateInvestments	278000000.0	USD
CY2021Q4	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	9042500000	USD
CY2020Q4	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	7910000000	USD
CY2021Q4	ivz	Collateral Assets Default Percentage CollateralAssetsDefaultPercentage	0.0052
CY2021	ivz	Collateralized Loan Obligations Terms Of Arrangements Interest Rate Margin Spread High CollateralizedLoanObligationsTermsOfArrangementsInterestRateMarginSpreadHigh	0.0925
CY2021	ivz	Issued Note Maturity Average Years IssuedNoteMaturityAverageYears	P11Y
CY2021	ivz	Notes Issued By Collateralized Loan Obligations Terms Of Arrangements Interest Rate Margin Spread Low NotesIssuedByCollateralizedLoanObligationsTermsOfArrangementsInterestRateMarginSpreadLow	0.0040
CY2021	ivz	Notes Issued By Collateralized Loan Obligations Terms Of Arrangements Interest Rate Margin Spread High NotesIssuedByCollateralizedLoanObligationsTermsOfArrangementsInterestRateMarginSpreadHigh	0.0868
CY2021Q4	us-gaap	Due From Affiliates DueFromAffiliates	681400000	USD
CY2020Q4	us-gaap	Due From Affiliates DueFromAffiliates	612000000	USD
CY2021Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	146500000	USD
CY2020Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	171600000	USD

Files In Submission

Name	View Source	Status
0000914208-22-000319-index-headers.html	Edgar Link	pending
0000914208-22-000319-index.html	Edgar Link	pending
0000914208-22-000319.txt	Edgar Link	pending
0000914208-22-000319-xbrl.zip	Edgar Link	pending
ex210subsidiarylisting2021.htm	Edgar Link	pending
ex231pwcconsentq42021.htm	Edgar Link	pending
ex31110k2021.htm	Edgar Link	pending
ex31210k2021.htm	Edgar Link	pending
ex32110k2021.htm	Edgar Link	pending
ex32210k2021.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
ivz-20211231.htm	Edgar Link	pending
ivz-20211231.xsd	Edgar Link	pending
ivz-20211231_cal.xml	Edgar Link	unprocessable
ivz-20211231_def.xml	Edgar Link	unprocessable
ivz-20211231_g1.jpg	Edgar Link	pending
ivz-20211231_g2.jpg	Edgar Link	pending
ivz-20211231_g3.jpg	Edgar Link	pending
ivz-20211231_g4.jpg	Edgar Link	pending
ivz-20211231_g5.jpg	Edgar Link	pending
ivz-20211231_g6.jpg	Edgar Link	pending
ivz-20211231_htm.xml	Edgar Link	completed
ivz-20211231_lab.xml	Edgar Link	unprocessable
ivz-20211231_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IVZ
Invesco Ltd. Stock $ivz

2021 Q4 Form 10-K Financial Statement

#000091420822000319 Filed on February 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVZ Invesco Ltd. Stock $ivz

2021 Q4 Form 10-K Financial Statement

#000091420822000319 Filed on February 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVZ
Invesco Ltd. Stock $ivz